Cumberland Pharmaceuticals Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Cumberland Pharmaceuticals Inc. stock issued during period, value, stock options exercised for the quarter ending 2016-12-31 was -$119.14K.
- Cumberland Pharmaceuticals Inc. stock issued during period, value, stock options exercised for the quarter ending 2016-09-30 was -$72.25K, a 146.13% decline year-over-year.
- Cumberland Pharmaceuticals Inc. stock issued during period, value, stock options exercised for the quarter ending 2016-06-30 was -$407.02K, a 233.55% decline year-over-year.
- Cumberland Pharmaceuticals Inc. stock issued during period, value, stock options exercised for the quarter ending 2016-03-31 was -$427.99K, a 1500.59% decline year-over-year.
- Cumberland Pharmaceuticals Inc. stock issued during period, value, stock options exercised for fiscal 2016 was -$1.03M, a 1013.60% decline from fiscal 2015.
- Cumberland Pharmaceuticals Inc. stock issued during period, value, stock options exercised for fiscal 2015 was $112.35K, a 93.20% decline from fiscal 2014.
- Cumberland Pharmaceuticals Inc. stock issued during period, value, stock options exercised for fiscal 2014 was $1.65M, a 24396.56% increase from fiscal 2013.
- Cumberland Pharmaceuticals Inc. stock issued during period, value, stock options exercised for fiscal 2013 was $6.75K, a 99.85% decline from fiscal 2012.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2017-12-31 | $372.50K 8-K · filed 2020-12-10 | |
| 2016-12-31 | -$119.14K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | -$1.03M 10-K · filed 2019-03-12 |
| 2016-09-30 | -$72.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$1.29M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-06-30 | -$407.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | -$1.06M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-03-31 | -$427.99K 10-Q · filed 2016-05-13 | -$346.20K derived: sum of 4 quarters · filed 2018-03-09 |
| 2015-12-31 | -$379.60K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $112.35K 10-K · filed 2018-03-09 |
| 2015-09-30 | $156.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $1.07M derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-06-30 | $304.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $1.28M derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-03-31 | $30.56K 10-Q · filed 2015-05-15 | $1.50M derived: sum of 4 quarters · filed 2017-03-13 |
| 2014-12-31 | $575.93K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $1.65M 10-K · filed 2017-03-13 |
| 2014-09-30 | $365.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $1.64M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | $523.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $744.10K derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-03-31 | $188.01K 10-Q · filed 2014-05-12 | -$242.65K derived: sum of 4 quarters · filed 2016-03-14 |
| 2013-12-31 | $559.95K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $6.75K 10-K · filed 2016-03-14 |
| 2013-09-30 | -$527.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $1.07M derived: sum of 4 quarters · filed 2015-03-09 |
| 2013-06-30 | -$463.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $2.95M derived: sum of 4 quarters · filed 2015-03-09 |
| 2013-03-31 | $437.41K 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $4.38M 10-K · filed 2015-03-09 |
| 2012-09-30 | $1.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | |
| 2011-12-31 | -$353.68K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $2.99M 10-K · filed 2014-03-11 |
| 2011-09-30 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | |
| 2010-12-31 | $5.24M 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |